Product Code: GVR-4-68040-369-1
Membrane Chromatography Market Trends
The global membrane chromatography market size was estimated at USD 284.45 million in 2023 and is anticipated to grow at a CAGR of 15.7% from 2024 to 2030. The growth of the market is driven by the rising demand for biopharmaceuticals and the growing regulatory focus on the cleaning validation of downstream purification processes. The demand for membrane chromatography is growing due to its efficiency and cost-effectiveness in biopharmaceutical purification processes.
Unlike traditional column chromatography, membrane chromatography offers higher binding capacities, faster processing times, and reduced buffer consumption. Its scalability and ease of use make it ideal for capturing and polishing large biomolecules, such as monoclonal antibodies and viral vectors, which are increasingly important in therapeutic and vaccine production. In addition, the rise in demand for biologics, coupled with stringent regulatory standards for purity and safety, drives the adoption of advanced purification technologies like membrane chromatography in the bioprocessing industry.
Furthermore, growing approvals by key market players from regulatory bodies for the manufacturing and supply of biopharmaceuticals aimed at treating various diseases are likely to fuel the demand over the coming years. For instance, in April 2024, Boehringer Ingelheim Biopharmaceuticals China (BioChina), in partnership with a customer, successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). This achievement is significant for BioChina as it demonstrates its commitment to meeting the stringent regulatory standards of the EMA and the U.S. FDA.
Moreover, the increase in R&D expenditure in the biopharmaceutical sector aided in the market's growth. For instance, as per the International Federation of Pharmaceutical Manufacturers & Associations' 2021 report on the pharmaceutical industry and global health, the biopharmaceutical industry's annual R&D spending surpasses that of aerospace and defense by 7.3 times, chemicals by 6.5 times, and software and computer services by 1.5 times. The report estimated that in 2022, over USD 202 billion were invested globally in biopharmaceutical research and development, reflecting the increasing popularity of biopharmaceuticals.
Furthermore, the growing number of product launches is further propelling the membrane chromatography market's growth. For instance, in August 2023, Waters Corporation launched the XBridge Premier GTx BEH SEC columns specifically designed for gene therapy applications. These new columns aim to address the unique challenges faced in gene therapy research and development, offering high performance and reliability.
Membrane chromatography has emerged as a valuable tool in the downstream processing of biopharmaceuticals due to its ability to streamline processes, reduce steps, and enhance overall efficiency. For instance, the article published in September 2023 on "Template-Assisted Membrane Crystallization Downstream Processing for Monoclonal Antibody Purification" highlights a novel approach to downstream processing for monoclonal antibody purification using template-assisted membrane crystallization. This technique involves using templates to control crystal growth on membranes, improving monoclonal antibody separation efficiency and purity. This technology offers several advantages, making it an attractive option for the biopharmaceutical industry.
Global Membrane Chromatography Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global membrane chromatography market report based on product, technique, end use, and region.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Capsules Cassette & Cartridges
- Syringe Filters
- Membrane Filters
- Filter Plates
- Spin Columns
- Others
- Technique Outlook (Revenue, USD Million, 2018 - 2030)
- Ion Exchange Membrane Chromatography
- Affinity Membrane Chromatography
- Hydrophobic Interaction Membrane Chromatography (HIMC)
- End use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and biotechnology companies
- CRO and CMO
- Academic research institutes
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technique
- 1.2.3. End use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Technique outlook
- 2.2.3. End-use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Membrane Chromatography Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Demand for Biopharmaceuticals
- 3.2.1.2. Continuous improvements in membrane materials
- 3.2.1.3. Advantages Over Traditional Chromatography
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Initial Costs
- 3.2.2.2. Complexity of Scale-Up
- 3.3. Membrane Chromatography Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Membrane Chromatography Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Membrane Chromatography Market: Product Movement Analysis
- 4.3. Membrane Chromatography Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Capsules Cassette & Cartridges
- 4.5.1. Capsules Cassette & Cartridges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Syringe Filters
- 4.6.1. Syringe Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Membrane Filters
- 4.7.1. Membrane Filters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.8. Filter Plates
- 4.8.1. Filter Plates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.9. Spin Columns
- 4.9.1. Spin Columns Market Revenue Estimates and Forecasts, 2018 - 2030
- 4.10. Others
- 4.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Membrane Chromatography Market: Technique Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Membrane Chromatography Market: Technique Movement Analysis
- 5.3. Membrane Chromatography Market by Technique Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Ion Exchange Membrane Chromatography
- 5.5.1. Ion Exchange Membrane Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Affinity Membrane Chromatography
- 5.6.1. Affinity Membrane Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Hydrophobic Interaction Membrane Chromatography (HIMC)
- 5.7.1. Hydrophobic Interaction Membrane Chromatography (HIMC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Membrane Chromatography Market: End use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Membrane Chromatography Market: End use Movement Analysis
- 6.3. Membrane Chromatography Market by End use Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Pharmaceutical and Biotechnology Companies
- 6.5.1. Pharmaceutical and Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. CRO and CMO
- 6.6.1. CRO and CMO Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Academic Research Institutes
- 6.7.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Membrane Chromatography Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional Membrane Chromatography Market Movement Analysis
- 7.3. Membrane Chromatography Market: Regional Estimates & Trend Analysis by Technology & End use
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. North America
- 7.5.1. North America Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. U.S. Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. Canada Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. Mexico Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.6. Europe Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. UK
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement scenario
- 7.6.7.5. UK Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.8. Germany
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Reimbursement scenario
- 7.6.8.5. Germany Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.9. France
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Competitive Scenario
- 7.6.9.3. Regulatory Framework
- 7.6.9.4. Reimbursement scenario
- 7.6.9.5. France Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.10. Italy
- 7.6.10.1. Key Country Dynamics
- 7.6.10.2. Competitive Scenario
- 7.6.10.3. Regulatory Framework
- 7.6.10.4. Reimbursement scenario
- 7.6.10.5. Italy Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.11. Spain
- 7.6.11.1. Key Country Dynamics
- 7.6.11.2. Competitive Scenario
- 7.6.11.3. Regulatory Framework
- 7.6.11.4. Reimbursement scenario
- 7.6.11.5. Spain Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.12. Denmark
- 7.6.12.1. Key Country Dynamics
- 7.6.12.2. Competitive Scenario
- 7.6.12.3. Regulatory Framework
- 7.6.12.4. Reimbursement scenario
- 7.6.12.5. Denmark Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.13. Sweden
- 7.6.13.1. Key Country Dynamics
- 7.6.13.2. Competitive Scenario
- 7.6.13.3. Regulatory Framework
- 7.6.13.4. Reimbursement scenario
- 7.6.13.5. Sweden Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.14. Norway
- 7.6.14.1. Key Country Dynamics
- 7.6.14.2. Competitive Scenario
- 7.6.14.3. Regulatory Framework
- 7.6.14.4. Reimbursement scenario
- 7.6.14.5. Norway Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Japan Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. China Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. India Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. South Korea Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Reimbursement scenario
- 7.7.6.5. Australia Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Reimbursement scenario
- 7.7.7.5. Thailand Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. Brazil Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. Argentina Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. Reimbursement scenario
- 7.9.2.5. South Africa Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Reimbursement scenario
- 7.9.3.5. Saudi Arabia Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. Reimbursement scenario
- 7.9.4.5. UAE Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Reimbursement scenario
- 7.9.5.5. Kuwait Membrane Chromatography Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. 3M
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Asahi Kasei
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Danaher Corporation
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Merck KGaA
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Cole-Parmer
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. AMBU, Inc.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Thermo Fisher Scientific
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. Sartorius AG
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Membrane Solutions
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Purilogics
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. Restek Corporation
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives